Martin Crowley v. HHS - Tdap, Guillian-Barre Syndrome (“GBS”) (2016)

Martin Crowley filed a petition on January 6, 2015, alleging that he developed Guillain-Barre Syndrome (GBS) as a result of receiving Hepatitis A, Hepatitis B, Meningococcal, and Tetanus-Diptheria-acellular Pertussis (TDaP) vaccines on August 8, 2012. He further alleged that he experienced residual effects from his injury for more than six months.

The respondent denied that the vaccines caused petitioner's GBS or any other injury. On April 21, 2016, the parties filed a joint stipulation for damages and attorneys' fees and costs.

The stipulation stated that Martin Crowley would receive a lump sum of $55,000.00 for all damages and a lump sum of $11,448.43 for attorneys' fees and costs, for a total award of $66,448.43. The Special Master, Thomas L.

Gowen, found the stipulation reasonable and adopted it as the decision of the Court, ordering judgment to be entered accordingly. Petitioner was represented by Scott W.

Rooney of Nemes, Rooney P.C., and respondent was represented by Adriana R. Teitel of the United States Department of Justice.

The public decision does not describe the specific onset of symptoms, medical tests, treatments, or the mechanism of causation.